Introduction:

Cancer is a complex disease with various characteristics such as unlimited proliferation,

angiogenesis, and invasion. One of the key characteristics of cancer is altered metabolism,
where the metabolism of cancer cells differs from that of normal cells. In particular, cancer cells
display altered carbohydrate metabolism, which allows them to generate energy and
biosynthetic intermediates required for proliferation. In this paper, we will explore the recent
advances in understanding the role of carbohydrate metabolism in cancer cells.

Overview of Carbohydrate Metabolism:

The metabolism of carbohydrates involves several pathways such as glycolysis, the pentose
phosphate pathway, and the tricarboxylic acid (TCA) cycle. Glycolysis is the process by which
glucose is converted into pyruvate, which can be further metabolized through the TCA cycle.
The pentose phosphate pathway is involved in the generation of NADPH, which is required for
biosynthetic reactions such as fatty acid synthesis. Cancer cells display altered carbohydrate
metabolism, with a preference for aerobic glycolysis (the Warburg effect), which involves the
conversion of glucose into lactate, even in the presence of oxygen. This allows cancer cells to
generate energy and biosynthetic intermediates in a manner that is distinct from normal cells.

Role of Carbohydrate Metabolism in Cancer Cells:

Recent research has highlighted the critical role of carbohydrate metabolism in cancer cells.
One of the key enzymes involved in glycolysis is hexokinase, which catalyzes the conversion of
glucose to glucose-6-phosphate. It has been shown that cancer cells overexpress hexokinase,
which allows them to uptake more glucose and promote glycolysis. In addition, cancer cells
display increased expression of lactate dehydrogenase, which is involved in the conversion of
pyruvate to lactate. This process allows cancer cells to maintain a low intracellular pH, which is
critical for their survival and proliferation.

Furthermore, cancer cells also display increased expression of glucose transporters such as
GLUT1, which allows for increased glucose uptake. Recent research has shown that targeting
GLUT1 can be an effective strategy for inhibiting the growth of cancer cells. In addition, the
pentose phosphate pathway has been shown to play a critical role in providing cancer cells with
the necessary biosynthetic intermediates required for proliferation. Targeting this pathway has
also been shown to be an effective strategy for inhibiting the growth of cancer cells.

Glycolysis:

Glycolysis is a metabolic pathway that converts glucose into pyruvate. In normal cells, pyruvate
is further metabolized through the TCA cycle and oxidative phosphorylation to generate ATP.
However, in cancer cells, pyruvate is predominantly converted into lactate, even in the presence
of oxygen. This process is known as aerobic glycolysis or the Warburg effect. Aerobic glycolysis
allows cancer cells to generate ATP and biosynthetic intermediates required for cell growth and
proliferation.

One of the key enzymes in glycolysis is hexokinase, which catalyzes the conversion of glucose
to glucose-6-phosphate. Cancer cells overexpress hexokinase, which increases glucose uptake
and promotes glycolysis. In addition, cancer cells also exhibit increased expression of glucose
transporters such as GLUT1, which facilitates glucose uptake.

Pentose Phosphate Pathway:

The pentose phosphate pathway (PPP) is a metabolic pathway that is involved in the generation
of NADPH and ribose-5-phosphate. NADPH is a critical cofactor for biosynthetic reactions such
as fatty acid synthesis and nucleotide synthesis. Ribose-5-phosphate is a precursor for
nucleotide synthesis.

Recent studies have shown that the PPP plays a critical role in supporting the growth and
proliferation of cancer cells. In particular, the PPP provides cancer cells with the necessary
NADPH and ribose-5-phosphate required for biosynthetic reactions. Cancer cells exhibit
increased expression of the rate-limiting enzyme of the PPP, glucose-6-phosphate
dehydrogenase (G6PD), which catalyzes the first step of the PPP. Inhibiting G6PD has been
shown to be an effective strategy for inhibiting the growth of cancer cells.

Tricarboxylic Acid Cycle:

The tricarboxylic acid (TCA) cycle, also known as the Krebs cycle, is a metabolic pathway that is
involved in the oxidation of acetyl-CoA to generate ATP. In normal cells, glucose is converted
into pyruvate through glycolysis, and pyruvate is further metabolized through the TCA cycle.
However, in cancer cells, pyruvate is predominantly converted into lactate, which is not further
metabolized through the TCA cycle.

Recent studies have shown that cancer cells exhibit altered TCA cycle metabolism. In particular,
cancer cells exhibit increased expression of isocitrate dehydrogenase 1 (IDH1) and IDH2, which
are key enzymes in the TCA cycle. Mutations in IDH1 and IDH2 have been identified in several
types of cancer, including gliomas, acute myeloid leukemia, and cholangiocarcinoma. Mutant
IDH1 and IDH2 produce an oncometabolite, D-2-hydroxyglutarate (D-2HG), which promotes
tumorigenesis by inhibiting the activity of alpha-ketoglutarate-dependent enzymes.

Conclusion:

In conclusion, the altered carbohydrate metabolism displayed by cancer cells is critical for their
survival and proliferation. The Warburg effect allows cancer cells to generate ATP and
biosynthetic intermediates required for cell growth and proliferation. Recent research has
highlighted the key enzymes and pathways involved in this process, which provides potential
targets for developing novel therapies for cancer. Targeting the enzymes involved in glycolysis,
such as hexokinase and lactate dehydrogenase, as well as the glucose transporters such as
GLUT1, may provide effective strategies for inhibiting the growth of cancer cells. Furthermore,
targeting the pentose phosphate pathway may also provide a potential avenue for developing
novel therapies for cancer.

CANCER TYPE Role of CArbohydrate Metabolism

Breast Cancer Increased glucose uptake and glycolysis,

leading to higher lactate production, promotes
tumor growth and invasiveness.

Lung Cancer Aerobic glycolysis and increased expression

of glycolytic enzymes such as pyruvate
kinase M2 (PKM2) promote tumor growth and
metastasis.

Colon Cancer Altered glucose metabolism, including

increased glucose uptake, glycolysis, and
pentose phosphate pathway (PPP) activity, is
associated with tumor progression and
resistance to therapy.

Liver Cancer Increased glucose uptake and glycolysis,

along with alterations in the tricarboxylic acid
(TCA) cycle and lipid metabolism, contribute
to tumor growth and proliferation.

Pancreatic Cancer Enhanced glucose uptake and glycolysis, as

well as upregulation of the pentose
phosphate pathway, support tumor growth
and resistance to chemotherapy.

Prostate Cancer Increased glucose uptake and metabolism,

particularly through the PPP, promote tumor
growth and resistance to therapy.

Brain Cancer Increased glycolysis, often called the

"Warburg effect," is a hallmark of many brain
tumors, including glioblastoma multiforme
(GBM).

Ovarian Cancer Increased glycolysis and lactate production,

mediated in part by hypoxia-inducible factor
1-alpha (HIF-1α), promote tumor growth and
metastasis.

Kidney Cancer Altered glucose metabolism, including

 increased glucose uptake and glycolysis, is a
common feature of many kidney tumors,
including renal cell carcinoma (RCC).

Leukemia Increased glucose metabolism, particularly

through the PPP, supports the high rate of
proliferation and survival of leukemia cells.

References

1. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell,
144(5), 646-674.
2. Cairns, R. A., Harris, I. S., & Mak, T. W. (2011). Regulation of cancer cell metabolism.
Nature Reviews Cancer, 11(2), 85-95.
3. Ward, P. S., & Thompson, C. B. (2012). Metabolic reprogramming: a cancer hallmark
even warburg did not anticipate. Cancer Cell, 21(3), 297-308.
4. Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009). Understanding the
Warburg effect: the metabolic requirements of cell proliferation. Science, 324(5930),
1029-1033.
5. DeBerardinis, R. J., & Chandel, N. S. (2016). Fundamentals of cancer metabolism.
Science Advances, 2(5), e1600200.
6. Ali F. Abdel-Wahab, Waheed Mahmoud, Randa M. Al-Harizy, Targeting glucose
metabolism to suppress cancer progression: prospective of anti-glycolytic cancer
therapy, Pharmacological Research, Volume 150, 2019, 104511, ISSN 1043-6618,
(https://www.sciencedirect.com/science/article/pii/S1043661819316731)
7. Nagao, Ayako, Minoru Kobayashi, Sho Koyasu, Christalle C. T. Chow, and Hiroshi
Harada. 2019. "HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of
Cancer Cells and Its Therapeutic Significance" International Journal of Molecular
Sciences 20, no. 2: 238. https://doi.org/10.3390/ijms20020238
8. Zahra Ghanbari Movahed, Mohsen Rastegari-Pouyani, Mohammad hossein
Mohammadi, Kamran Mansouri, Cancer cells change their glucose metabolism to
overcome increased ROS: One step from cancer cell to cancer stem cell?, Biomedicine
& Pharmacotherapy, Volume 112, 2019, 108690, ISSN 0753-3322,
(https://www.sciencedirect.com/science/article/pii/S0753332218388012)
9. Varghese, Elizabeth, Samson Mathews Samuel, Alena Líšková, Marek Samec, Peter
Kubatka, and Dietrich Büsselberg. 2020. "Targeting Glucose Metabolism to Overcome
Resistance to Anticancer Chemotherapy in Breast Cancer" Cancers 12, no. 8: 2252.
https://doi.org/10.3390/cancers12082252